慢性阻塞性肺疾病患者炎症指标及免疫球蛋白与肺功能及肺通气功能障碍严重程度的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

安徽省重点研究与开发计划项目(2022e07020058)


Relationship of inflammatory indexes and immunoglobulins with lung function and pulmonary ventilation dysfunction severity in patients with
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨慢性阻塞性肺疾病(COPD)患者炎症指标及免疫球蛋白与肺功能及肺通气功能障碍严重程度的关系。方法 将2020年1月—2024年6月本院收治的107例COPD患者依据肺通气功能障碍严重程度分级分为轻度、中度组58例和中重度、重度、极重度组49例,另选取同期于本院体检者102例作为对照组。所有研究对象均在入院后测定炎症指标[C反应蛋白(CRP)、降钙素原(PCT)、白介素-6(IL-6)]、免疫球蛋白(IgM、IgA、IgG)和肺功能指标[第1秒用力呼气容量(FEV1)、用力肺活量(FVC)、FEV1/FVC]。采用Pearson相关性分析CRP、PCT、IL-6、IgM、IgA、IgG与FEV1、FVC、FEV1/FVC的相关性,以Spearman相关性分析CRP、PCT、IL-6、IgM、IgA、IgG与肺通气功能障碍严重程度分级的关系。结果 研究组的CRP、PCT、IL-6水平高于对照组,IgA、IgG、FEV1、FVC、FEV1/FVC低于对照组(P<0.05)。Pearson相关性分析显示,COPD患者CRP、PCT、IL-6水平与FEV1、FVC、FEV1/FVC呈负相关(r=-0.482,-0.476,-0.374;-0.468,-0.453,-0.363;-0.376,-0.364,-0.345,P<0.05);IgA、IgG与FEV1、FVC、FEV1/FVC呈正相关(r=0.403,0.412,0.373;0.345,0.327,0.308,P<0.05)。中重度、重度、极重度组患者的CRP、PCT、IL-6水平高于轻度、中度组,IgA、IgG低于轻度、中度组(P<0.05);不同肺通气功能障碍严重程度分级患者IgM间比较差异不明显(P>0.05)。Spearman相关性分析,CRP、PCT、IL-6水平与肺通气功能障碍严重程度分级呈正相关(r=0.518,0.513,0.496,P<0.05);IgA、IgG与肺通气功能障碍严重程度分级呈负相关(r=-0.293,-0.285,P<0.05)。结论 COPD患者炎症指标及免疫球蛋白与肺功能及肺通气功能障碍严重程度分级密切相关,临床可通过早期测定炎症指标及免疫球蛋白水平为COPD患者肺功能及病情严重程度的评估提供一定的参考价值

    Abstract:

    Objective To investigate the relationship between inflammatory indexes, immunoglobulins and pulmonary function, severity of pulmonary ventilation dysfunction in patients with chronic obstructive pulmonary disease (COPD). Methods 107 patients with COPD in the hospital from January 2020 to June 2024 were classified into mild-to-moderate group (n=58) and moderately severe, severe and extremely severe group (n=49) by means of the severity grading of pulmonary ventilation dysfunction. Another 102 health examination subjects during the same period were selected as the control group. Inflammatory indexes [C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6)], immunoglobulins (IgM, IgA, IgG) and lung function indexes (FEV1, FVC, FEV1/FVC) were measured among all study subjects after admission. Pearson correlation analysis was applied to analyze the correlation between CRP, PCT, IL-6, IgM, IgA, IgG and FEV1, FVC, FEV1/FVC. Spearman correlation analysis was adopted to analyze the relationship between CRP, PCT, IL-6, IgM, IgA, IgG and severity grading of pulmonary ventilation dysfunction. Results The CRP, PCT and IL-6 levels in the study group were higher while the IgA, IgG, FEV1, FVC and FEV1/FVC were lower (P<0.05). Pearson correlation analysis indicated that the levels of CRP, PCT and IL-6 were inversely related to FEV1, FVC and FEV1/FVC (r=-0.482,-0.476, -0.374; -0.468, -0.453, -〗0.363; -0.376,-0.364, -0.345, P<0.05), and IgA and IgG were positively correlated with FEV1, FVC and FEV1/FVC (r=0.403, 0.412, 0.373; 0.345, 0.327, 0.308, P<0.05). The levels of CRP, PCT and IL-6 in severe and extremely severe groups were higher than those in mild and moderate groups, In the moderate group, IgA and IgG were lower than those in the mild and moderate groups (P<0.05).There was no obvious difference in IgM among patients with different grades of pulmonary ventilation dysfunction severity (P>0.05). With regard to Spearman correlation analysis, the CRP, PCT and IL-6 were positively associated with severity grading of pulmonary ventilation dysfunction (r=0.518, 0.513, 0.496, P<0.05). IgA and IgG were inversely proportional to pulmonary ventilation dysfunction severity grading (r=-0.293, -0.285, P<0.05).Conclusion Inflammatory indexes and immunoglobulins in COPD patients are closely related to lung function and severity grading of pulmonary ventilation dysfunction. Clinically, early determination of inflammatory indexes and immunoglobulins can provide certain reference value for the evaluation of lung function and severity of COPD patients

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-01-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司